Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Kangling Pharmaceutical is a comprehensive pharmaceutical enterprise based in Lu'an, Anhui Province, China. Founded in 2011, the company focuses on the research, development, manufacturing, and sales of chemical drugs, including active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio covers several therapeutic areas such as anti-infectives, cardiovascular diseases, and respiratory conditions. The company operates modern manufacturing facilities that adhere to national GMP standards, ensuring high-quality production for both domestic and international markets. Key products include widely used antibiotics like Cefixime and Azithromycin, as well as cardiovascular treatments like Amlodipine. Anhui Kangling Pharmaceutical is committed to technological innovation and maintains a strong presence in the Chinese pharmaceutical manufacturing sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Kangling Pharmaceutical.